Clinical Trial: Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms

Brief Summary: Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) in patients with resistance to Eculizumab due to complement C5 polymorphisms.